New endoscopic technique for better evaluation of colorectal cancer
SESORRS endoscopy for the staging and evaluation of colorectal cancer
This study is testing a new way to help doctors find and understand colorectal cancer better during procedures, using a special technique that could lead to more accurate diagnoses and better treatment for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11008930 on NIH RePORTER |
What this research studies
This research investigates a novel endoscopic technique called SESORRS, which combines spatially offset Raman spectroscopy with special contrast agents to improve the detection and staging of colorectal cancer. By using this advanced method, the researchers aim to provide more detailed information about tumor invasion and the necessary surgical margins compared to traditional white light endoscopy. The study will involve testing this technique in preclinical models to assess its effectiveness in real-time evaluations during procedures. Patients may benefit from improved diagnostic accuracy and potentially better treatment outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with colorectal cancer who require staging and evaluation prior to surgical intervention.
Not a fit: Patients with early-stage colorectal cancer that does not require surgical intervention may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate staging of colorectal cancer, improving surgical outcomes and patient prognosis.
How similar studies have performed: Other research has shown promising results using advanced imaging techniques for cancer detection, suggesting that this approach may also yield significant benefits.
Where this research is happening
Boston, United States
- Dana-Farber Cancer Inst — Boston, United States (Active)
Researchers
- Principal investigator: Nicolson, Fay — Dana-Farber Cancer Inst
- Study coordinator: Nicolson, Fay
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.